Every SEC Form 3/4/5 on record for this filer (CIK 1683607) — 4 issuers, 92 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | Director | 2020-06-15 → 2026-06-30 | 32 | — |
| REGN | REGENERON PHARMACEUTICALS, INC. | Director | 2016-09-12 → 2026-01-08 | 34 | −$22M |
| CDTX | Cidara Therapeutics, Inc. | Director | 2021-01-25 → 2026-01-07 | 9 | — |
| KLDO | Kaleido Biosciences, Inc. | Director · lapsed | 2019-02-27 → 2021-07-01 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| REGN | 2026-01-07 | Sell | 1,500 | $800.00 | $1M | 1,703 |
| REGN | 2025-11-20 | Sell | 760 | $750.00 | $570,000 | 1,548 |
2 of 4 issuers are covered and open a security page; the rest are on file here only.